E3 ubiquitin ligases in nasopharyngeal carcinoma and implications for therapies

citation_journal_title=MedComm; citation_title=Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma; citation_author=QY Zhu, GX Zhao, Y Li, G Talakatta, HQ Mai, QT Le, LS Young, MS Zeng; citation_volume=2; citation_publication_date=2021; citation_pages=175-206; citation_doi=10.1002/mco2.32; citation_id=CR1 citation_journal_title=Lancet (London, England); citation_title=Nasopharyngeal carcinoma; citation_author=YP Chen, ATC Chan, QT Le, P Blanchard, Y Sun, J Ma; citation_volume=394; citation_publication_date=2019; citation_pages=64-80; citation_doi=10.1016/s0140-6736(19)30956-0; citation_id=CR2 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clinicians 68: 394–424.  https://doi.org/10.3322/caac.21492 Yang J, Han J, He J, Duan B, Gou Q, Ai P, Liu L, Li Y, Ren K, Wang F et al (2020) Real-world cost-effectiveness analysis of gemcitabine and cisplatin compared to docetaxel and cisplatin plus fluorouracil induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma. Front Oncol 10:594756.  https://doi.org/10.3389/fonc.2020.594756 citation_journal_title=Lancet Oncol; citation_title=Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis; citation_author=P Blanchard, A Lee, S Marguet, J Leclercq, WT Ng, J Ma, AT Chan, PY Huang, E Benhamou, G Zhu; citation_volume=16; citation_publication_date=2015; citation_pages=645-655; citation_doi=10.1016/s1470-2045(15)70126-9; citation_id=CR5 citation_journal_title=J Clin Oncol : Official J Am Soc Clin Oncol; citation_title=Management of nasopharyngeal carcinoma: current practice and future perspective; citation_author=AW Lee, BB Ma, WT Ng, AT Chan; citation_volume=33; citation_publication_date=2015; citation_pages=3356-3364; citation_doi=10.1200/jco.2015.60.9347; citation_id=CR6 citation_journal_title=Head Neck; citation_title=Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: a meta-analysis; citation_author=YH Leong, YY Soon, KM Lee, LC Wong, IWK Tham, FCH Ho; citation_volume=40; citation_publication_date=2018; citation_pages=622-631; citation_doi=10.1002/hed.24993; citation_id=CR7 Almobarak AA, Jebreel AB, Abu-Zaid A (2019) Molecular targeted therapy in the management of recurrent and metastatic nasopharyngeal carcinoma: a comprehensive literature review. Cureus 11:e4210.  https://doi.org/10.7759/cureus.4210 citation_journal_title=Int J Biochem Cell Biol; citation_title=Ubiquitination: friend and foe in cancer; citation_author=MA Mansour; citation_volume=101; citation_publication_date=2018; citation_pages=80-93; citation_doi=10.1016/j.biocel.2018.06.001; citation_id=CR9 Snyder NA, Silva GM (2021) Deubiquitinating enzymes (DUBs): regulation, homeostasis, and oxidative stress response. J Biol Chem 297:101077. https://doi.org/10.1016/j.jbc.2021.101077 citation_journal_title=Curr Opin Cell Biol; citation_title=Ubiquitin, proteasomes, and the regulation of intracellular protein degradation; citation_author=M Hochstrasser; citation_volume=7; citation_publication_date=1995; citation_pages=215-223; citation_doi=10.1016/0955-0674(95)80031-x; citation_id=CR11 citation_journal_title=Nat Struct Mol Biol; citation_title=DNA damage: ubiquitin marks the spot; citation_author=EJ Bennett, JW Harper; citation_volume=15; citation_publication_date=2008; citation_pages=20-22; citation_doi=10.1038/nsmb0108-20; citation_id=CR12 citation_journal_title=Mol Cell; citation_title=Nonproteolytic functions of ubiquitin in cell signaling; citation_author=ZJ Chen, LJ Sun; citation_volume=33; citation_publication_date=2009; citation_pages=275-286; citation_doi=10.1016/j.molcel.2009.01.014; citation_id=CR13 citation_journal_title=Biochem Biophys Acta; citation_title=RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination; citation_author=MB Metzger, JN Pruneda, RE Klevit, AM Weissman; citation_volume=1843; citation_publication_date=2014; citation_pages=47-60; citation_doi=10.1016/j.bbamcr.2013.05.026; citation_id=CR14 citation_journal_title=Nature; citation_title=Targeting the ubiquitin system in cancer therapy; citation_author=D Hoeller, I Dikic; citation_volume=458; citation_publication_date=2009; citation_pages=438-444; citation_doi=10.1038/nature07960; citation_id=CR15 citation_journal_title=Cell; citation_title=Types of ubiquitin ligases; citation_author=FE Morreale, H Walden; citation_volume=165; citation_publication_date=2016; citation_pages=248-248.e241; citation_doi=10.1016/j.cell.2016.03.003; citation_id=CR16 citation_journal_title=Nat Rev Mol Cell Biol; citation_title=Function and regulation of cullin-RING ubiquitin ligases; citation_author=MD Petroski, RJ Deshaies; citation_volume=6; citation_publication_date=2005; citation_pages=9-20; citation_doi=10.1038/nrm1547; citation_id=CR17 citation_journal_title=Cell Signal; citation_title=Physiological functions of FBW7 in cancer and metabolism; citation_author=K Shimizu, NT Nihira, H Inuzuka, W Wei; citation_volume=46; citation_publication_date=2018; citation_pages=15-22; citation_doi=10.1016/j.cellsig.2018.02.009; citation_id=CR18 citation_journal_title=Pharmacol Res; citation_title=Skp1: implications in cancer and SCF-oriented anti-cancer drug discovery; citation_author=M Hussain, Y Lu, YQ Liu, K Su, J Zhang, J Liu, GB Zhou; citation_volume=111; citation_publication_date=2016; citation_pages=34-42; citation_doi=10.1016/j.phrs.2016.05.027; citation_id=CR19 citation_journal_title=Genes Dev; citation_title=Systematic analysis and nomenclature of mammalian F-box proteins; citation_author=J Jin, T Cardozo, RC Lovering, SJ Elledge, M Pagano, JW Harper; citation_volume=18; citation_publication_date=2004; citation_pages=2573-2580; citation_doi=10.1101/gad.1255304; citation_id=CR20 citation_journal_title=Adv Exp Med Biol; citation_title=The tripartite motif: structure and function; citation_author=L Micale, E Chaignat, C Fusco, A Reymond, G Merla; citation_volume=770; citation_publication_date=2012; citation_pages=11-25; citation_doi=10.1007/978-1-4614-5398-7_2; citation_id=CR21 citation_journal_title=Front Immunol; citation_title=Structure of TRAF family: current understanding of receptor recognition; citation_author=HH Park; citation_volume=9; citation_publication_date=2018; citation_pages=1999; citation_doi=10.3389/fimmu.2018.01999; citation_id=CR22 citation_journal_title=Front Physiol; citation_title=HECT E3 ligases: a tale with multiple facets; citation_author=J Weber, S Polo, E Maspero; citation_volume=10; citation_publication_date=2019; citation_pages=370; citation_doi=10.3389/fphys.2019.00370; citation_id=CR23 citation_journal_title=Proc Natl Acad Sci USA; citation_title=A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase; citation_author=JM Huibregtse, M Scheffner, S Beaudenon, PM Howley; citation_volume=92; citation_publication_date=1995; citation_pages=2563-2567; citation_doi=10.1073/pnas.92.7.2563; citation_id=CR24 citation_journal_title=Cellular and molecular life sciences : CMLS; citation_title=Regulating the human HECT E3 ligases; citation_author=J Sluimer, B Distel; citation_volume=75; citation_publication_date=2018; citation_pages=3121-3141; citation_doi=10.1007/s00018-018-2848-2; citation_id=CR25 citation_journal_title=Nat Rev Mol Cell Biol; citation_title=Physiological functions of the HECT family of ubiquitin ligases; citation_author=D Rotin, S Kumar; citation_volume=10; citation_publication_date=2009; citation_pages=398-409; citation_doi=10.1038/nrm2690; citation_id=CR26 Wang Y, Argiles-Castillo D, Kane EI, Zhou A, Spratt DE (2020) HECT E3 ubiquitin ligases - emerging insights into their biological roles and disease relevance. J Cell Sci 133.  https://doi.org/10.1242/jcs.228072 citation_journal_title=Biol Chem; citation_title=Structural mechanisms of HECT-type ubiquitin ligases; citation_author=S Lorenz; citation_volume=399; citation_publication_date=2018; citation_pages=127-145; citation_doi=10.1515/hsz-2017-0184; citation_id=CR28 citation_journal_title=Biochem Biophys Res Commun; citation_title=U-box proteins as a new family of ubiquitin ligases; citation_author=S Hatakeyama, KI Nakayama; citation_volume=302; citation_publication_date=2003; citation_pages=635-645; citation_doi=10.1016/s0006-291x(03)00245-6; citation_id=CR29 citation_journal_title=Biochemistry; citation_title=The Prp19 U-box crystal structure suggests a common dimeric architecture for a class of oligomeric E3 ubiquitin ligases; citation_author=CW Vander Kooi, MD Ohi, JA Rosenberg, ML Oldham, ME Newcomer, KL Gould, WJ Chazin; citation_volume=45; citation_publication_date=2006; citation_pages=121-130; citation_doi=10.1021/bi051787e; citation_id=CR30 citation_journal_title=Int J Biochem Cell Biol; citation_title=CHIP: a quality-control E3 ligase collaborating with molecular chaperones; citation_author=S Murata, T Chiba, K Tanaka; citation_volume=35; citation_publication_date=2003; citation_pages=572-578; citation_doi=10.1016/s1357-2725(02)00394-1; citation_id=CR31 citation_journal_title=Mol Cancer Res: MCR; citation_title=Aurora kinase A promotes AR degradation via the E3 ligase CHIP; citation_author=S Sarkar, DL Brautigan, JM Larner; citation_volume=15; citation_publication_date=2017; citation_pages=1063-1072; citation_doi=10.1158/1541-7786.Mcr-17-0062; citation_id=CR32 citation_journal_title=EMBO Rep; citation_title=RBR E3-ligases at work; citation_author=JJ Smit, TK Sixma; citation_volume=15; citation_publication_date=2014; citation_pages=142-154; citation_doi=10.1002/embr.201338166; citation_id=CR33 citation_journal_title=J Mol Biol; citation_title=RING-between-RING E3 ligases: emerging themes amid the variations; citation_author=KK Dove, RE Klevit; citation_volume=429; citation_publication_date=2017; citation_pages=3363-3375; citation_doi=10.1016/j.jmb.2017.08.008; citation_id=CR34 citation_journal_title=Semin Cancer Biol; citation_title=RBR E3 ubiquitin ligases in tumorigenesis; citation_author=P Wang, X Dai, W Jiang, Y Li, W Wei; citation_volume=67; citation_publication_date=2020; citation_pages=131-144; citation_doi=10.1016/j.semcancer.2020.05.002; citation_id=CR35 citation_journal_title=Cancer Treat Rev; citation_title=PI3K/Akt signalling pathway and cancer; citation_author=JA Fresno Vara, E Casado, J Castro, P Cejas, C Belda-Iniesta, M González-Barón; citation_volume=30; citation_publication_date=2004; citation_pages=193-204; citation_doi=10.1016/j.ctrv.2003.07.007; citation_id=CR36 citation_journal_title=Science (New York, NY); citation_title=The phosphoinositide 3-kinase pathway; citation_author=LC Cantley; citation_volume=296; citation_publication_date=2002; citation_pages=1655-1657; citation_doi=10.1126/science.296.5573.1655; citation_id=CR37 citation_journal_title=Semin Cancer Biol; citation_title=PDK1: at the crossroad of cancer signaling pathways; citation_author=PA Gagliardi, A Puliafito, L Primo; citation_volume=48; citation_publication_date=2018; citation_pages=27-35; citation_doi=10.1016/j.semcancer.2017.04.014; citation_id=CR38 Wang W, Wen Q, Xu L, Xie G, Li J, Luo J, Chu S, Shi L, Huang D, Li J et al (2014) Activation of Akt/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma. PloS One 9:e106098.  https://doi.org/10.1371/journal.pone.0106098 Fan X, Xie X, Yang M, Wang Y, Wu H, Deng T, Weng X, Wen W, Nie G (2021) YBX3 mediates the metastasis of nasopharyngeal carcinoma via PI3K/AKT signaling. Front Oncol 11:617621. https://doi.org/10.3389/fonc.2021.617621 Pan S, Liang S, Wang X (2021) ADORA1 promotes nasopharyngeal carcinoma cell progression through regulation of PI3K/AKT/GSK-3β/β-catenin signaling. Life Sci 278:119581.  https://doi.org/10.1016/j.lfs.2021.119581 citation_journal_title=Can Res; citation_title=Long noncoding RNA FAM225A promotes nasopharyngeal carcinoma tumorigenesis and metastasis by acting as ceRNA to sponge miR-590-3p/miR-1275 and upregulate ITGB3; citation_author=ZQ Zheng, ZX Li, GQ Zhou, L Lin, LL Zhang, JW Lv, XD Huang, RQ Liu, F Chen, XJ He; citation_volume=79; citation_publication_date=2019; citation_pages=4612-4626; citation_doi=10.1158/0008-5472.Can-19-0799; citation_id=CR42 citation_journal_title=Int J Radiat Biol; citation_title=The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression; citation_author=P Vaupel, H Schmidberger, A Mayer; citation_volume=95; citation_publication_date=2019; citation_pages=912-919; citation_doi=10.1080/09553002.2019.1589653; citation_id=CR43 citation_journal_title=Med Res Rev; citation_title=Skp2 in the ubiquitin-proteasome system: a comprehensive review; citation_author=MD Asmamaw, Y Liu, YC Zheng, XJ Shi, HM Liu; citation_volume=40; citation_publication_date=2020; citation_pages=1920-1949; citation_doi=10.1002/med.21675; citation_id=CR44 Agrawal Y, Sharma T, Islam S, Nadkarni KS, Santra MK (2022) F-box protein FBXO41 suppresses breast cancer growth by inducing autophagic cell death through facilitating proteasomal degradation of oncogene SKP2. Int J Biochem Cell B 147:106228. https://doi.org/10.1016/j.biocel.2022.106228 citation_journal_title=Cell Death Dis; citation_title=Skp2 stabilizes Mcl-1 and confers radioresistance in colorectal cancer; citation_author=X Yu, L Zhou, W Liu, L Liu, F Gao, W Li, H Liu; citation_volume=13; citation_publication_date=2022; citation_pages=249; citation_doi=10.1038/s41419-022-04685-0; citation_id=CR46 Chen M, Lingadahalli S, Narwade N, Lei KMK, Liu S, Zhao Z, Zheng Y, Lu Q, Tang AHN, Poon TCW et al (2022) TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. EMBO Rep 23:e53468. https://doi.org/10.15252/embr.202153468 Ji Y, Yang S, Yan X, Zhu L, Yang W, Yang X, Yu F, Shi L, Zhu X, Lu Y et al (2021) CircCRIM1 promotes hepatocellular carcinoma proliferation and angiogenesis by sponging miR-378a-3p and regulating SKP2 expression. Front Cell Dev Biol 9:796686.  https://doi.org/10.3389/fcell.2021.796686 citation_journal_title=Chin J Cancer; citation_title=Correlation of Skp2 overexpression to prognosis of patients with nasopharyngeal carcinoma from South China; citation_author=HM Xu, Y Liang, Q Chen, QN Wu, YM Guo, GP Shen, RH Zhang, ZW He, YX Zeng, FY Xie; citation_volume=30; citation_publication_date=2011; citation_pages=204-212; citation_doi=10.5732/cjc.010.10403; citation_id=CR49 citation_journal_title=Oncotarget; citation_title=E3-ligase Skp2 predicts poor prognosis and maintains cancer stem cell pool in nasopharyngeal carcinoma; citation_author=J Wang, Y Huang, Z Guan, JL Zhang, HK Su, W Zhang, CF Yue, M Yan, S Guan, QQ Liu; citation_volume=5; citation_publication_date=2014; citation_pages=5591-5601; citation_doi=10.18632/oncotarget.2149; citation_id=CR50 citation_journal_title=Int J Radiat Oncol Biol Phys; citation_title=Effect of S-phase kinase-associated protein 2 expression on distant metastasis and survival in nasopharyngeal carcinoma patients; citation_author=FM Fang, CY Chien, CF Li, WY Shiu, CH Chen, HY Huang; citation_volume=73; citation_publication_date=2009; citation_pages=202-207; citation_doi=10.1016/j.ijrobp.2008.04.008; citation_id=CR51 citation_journal_title=Oncogene; citation_title=Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin; citation_author=X Yu, R Wang, Y Zhang, L Zhou, W Wang, H Liu, W Li; citation_volume=38; citation_publication_date=2019; citation_pages=7457-7472; citation_doi=10.1038/s41388-019-0955-7; citation_id=CR52 citation_journal_title=Eur Rev Med Pharmacol Sci; citation_title=TRPP2 promotes the proliferation of nasopharyngeal carcinoma through upregulating Skp2/c-Myc; citation_author=T Zhang, GD Yu, HP Ye, Y Jin; citation_volume=24; citation_publication_date=2020; citation_pages=8001-8007; citation_doi=10.26355/eurrev_202008_22483; citation_id=CR53 citation_journal_title=Onco Targets Ther; citation_title=Curcumin exerts its antitumor activity through regulation of miR-7/Skp2/p21 in nasopharyngeal carcinoma cells; citation_author=S Feng, Y Wang, R Zhang, G Yang, Z Liang, Z Wang, G Zhang; citation_volume=10; citation_publication_date=2017; citation_pages=2377-2388; citation_doi=10.2147/ott.S130055; citation_id=CR54 citation_journal_title=Nat Rev Cancer; citation_title=FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation; citation_author=M Welcker, BE Clurman; citation_volume=8; citation_publication_date=2008; citation_pages=83-93; citation_doi=10.1038/nrc2290; citation_id=CR55 citation_journal_title=Science (New York, NY); citation_title=Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1; citation_author=N Agrawal, MJ Frederick, CR Pickering, C Bettegowda, K Chang, RJ Li, C Fakhry, TX Xie, J Zhang, J Wang; citation_volume=333; citation_publication_date=2011; citation_pages=1154-1157; citation_doi=10.1126/science.1206923; citation_id=CR56 citation_journal_title=Oncogene; citation_title=Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy; citation_author=L Xiao, ZY Hu, X Dong, Z Tan, W Li, M Tang, L Chen, L Yang, Y Tao, Y Jiang; citation_volume=33; citation_publication_date=2014; citation_pages=4568-4578; citation_doi=10.1038/onc.2014.32; citation_id=CR57 Zhang P, Shao Y, Quan F, Liu L, Yang J (2021) FBP1 enhances the radiosensitivity by suppressing glycolysis via the FBXW7/mTOR axis in nasopharyngeal carcinoma cells. Life Sci 283:119840. https://doi.org/10.1016/j.lfs.2021.119840 Wu H, Arron JR (2003) TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. BioEssays: news and reviews in molecular, cellular and developmental biology 25:1096–1105.  https://doi.org/10.1002/bies.10352 citation_journal_title=Cancer Cell Int; citation_title=The relationship between TRAF6 and tumors; citation_author=J Li, N Liu, L Tang, B Yan, X Chen, J Zhang, C Peng; citation_volume=20; citation_publication_date=2020; citation_pages=429; citation_doi=10.1186/s12935-020-01517-z; citation_id=CR60 citation_journal_title=Biomed Res Int; citation_title=Mechanism by which TRAF6 participates in the immune regulation of autoimmune diseases and cancer; citation_author=J Wang, X Wu, M Jiang, G Tai; citation_volume=2020; citation_publication_date=2020; citation_pages=4607197; citation_doi=10.1155/2020/4607197; citation_id=CR61 citation_journal_title=FEBS Lett; citation_title=TRAF6 interacts with and ubiquitinates PIK3CA to enhance PI3K activation; citation_author=Z Wang, Y Liu, S Huang, M Fang; citation_volume=592; citation_publication_date=2018; citation_pages=1882-1892; citation_doi=10.1002/1873-3468.13080; citation_id=CR62 citation_journal_title=J Exp Clin Cancer Res : CR; citation_title=NOTCH2 negatively regulates metastasis and epithelial-mesenchymal transition via TRAF6/AKT in nasopharyngeal carcinoma; citation_author=Y Zou, R Yang, ML Huang, YG Kong, JF Sheng, ZZ Tao, L Gao, SM Chen; citation_volume=38; citation_publication_date=2019; citation_pages=456; citation_doi=10.1186/s13046-019-1463-x; citation_id=CR63 citation_journal_title=EBioMedicine; citation_title=Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway; citation_author=Y Liu, Q Jiang, X Liu, X Lin, Z Tang, C Liu, J Zhou, M Zhao, X Li, Z Cheng; citation_volume=48; citation_publication_date=2019; citation_pages=386-404; citation_doi=10.1016/j.ebiom.2019.08.040; citation_id=CR64 citation_journal_title=Proc Natl Acad Sci USA; citation_title=Solubility-based genetic screen identifies RING finger protein 126 as an E3 ligase for activation-induced cytidine deaminase; citation_author=RK Delker, Y Zhou, A Strikoudis, CE Stebbins, FN Papavasiliou; citation_volume=110; citation_publication_date=2013; citation_pages=1029-1034; citation_doi=10.1073/pnas.1214538110; citation_id=CR65 citation_journal_title=Mol Cell; citation_title=Cytosolic quality control of mislocalized proteins requires RNF126 recruitment to Bag6; citation_author=MC Rodrigo-Brenni, E Gutierrez, RS Hegde; citation_volume=55; citation_publication_date=2014; citation_pages=227-237; citation_doi=10.1016/j.molcel.2014.05.025; citation_id=CR66 citation_journal_title=Onco Targets Ther; citation_title=Overexpression of RNF126 promotes the development of colorectal cancer via enhancing p53 ubiquitination and degradation; citation_author=S Wang, T Wang, L Wang, L Zhong, K Li; citation_volume=13; citation_publication_date=2020; citation_pages=10917-10929; citation_doi=10.2147/ott.S271855; citation_id=CR67 citation_journal_title=Can Res; citation_title=E3 ubiquitin ligase RNF126 promotes cancer cell proliferation by targeting the tumor suppressor p21 for ubiquitin-mediated degradation; citation_author=X Zhi, D Zhao, Z Wang, Z Zhou, C Wang, W Chen, R Liu, C Chen; citation_volume=73; citation_publication_date=2013; citation_pages=385-394; citation_doi=10.1158/0008-5472.Can-12-0562; citation_id=CR68 Yu C, Xue B, Li J, Zhang Q (2022) Tumor cell-derived exosome RNF126 affects the immune microenvironment and promotes nasopharyngeal carcinoma progression by regulating PTEN ubiquitination. Apoptosis: Int J Program Cell Death 27:590–605. https://doi.org/10.1007/s10495-022-01738-9 citation_journal_title=J Biol Chem; citation_title=Ring finger protein 149 is an E3 ubiquitin ligase active on wild-type v-Raf murine sarcoma viral oncogene homolog B1 (BRAF); citation_author=SW Hong, DH Jin, JS Shin, JH Moon, YS Na, KA Jung, SM Kim, JC Kim, KP Kim, YS Hong; citation_volume=287; citation_publication_date=2012; citation_pages=24017-24025; citation_doi=10.1074/jbc.M111.319822; citation_id=CR70 citation_journal_title=Can Res; citation_title=Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer; citation_author=VS Nair, O Gevaert, G Davidzon, S Napel, EE Graves, CD Hoang, JB Shrager, A Quon, DL Rubin, SK Plevritis; citation_volume=72; citation_publication_date=2012; citation_pages=3725-3734; citation_doi=10.1158/0008-5472.Can-11-3943; citation_id=CR71 citation_journal_title=BMC Genomics; citation_title=Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans; citation_author=JM Winter, NL Curry, DM Gildea, KA Williams, M Lee, Y Hu, NPS Crawford; citation_volume=19; citation_publication_date=2018; citation_pages=450; citation_doi=10.1186/s12864-018-4827-2; citation_id=CR72 citation_journal_title=Gene; citation_title=The relation between PI3K/AKT signalling pathway and cancer; citation_author=S Noorolyai, N Shajari, E Baghbani, S Sadreddini, B Baradaran; citation_volume=698; citation_publication_date=2019; citation_pages=120-128; citation_doi=10.1016/j.gene.2019.02.076; citation_id=CR73 citation_journal_title=Cell Death Dis; citation_title=MFSD4A inhibits the malignant progression of nasopharyngeal carcinoma by targeting EPHA2; citation_author=H Yang, G Qin, Z Luo, X Kong, C Gan, R Zhang, W Jiang; citation_volume=13; citation_publication_date=2022; citation_pages=332; citation_doi=10.1038/s41419-022-04793-x; citation_id=CR74 citation_journal_title=Nat Rev Mol Cell Biol; citation_title=Cbl: many adaptations to regulate protein tyrosine kinases; citation_author=CB Thien, WY Langdon; citation_volume=2; citation_publication_date=2001; citation_pages=294-307; citation_doi=10.1038/35067100; citation_id=CR75 Daniels SR, Liyasova M, Kales SC, Nau MM, Ryan PE, Green JE, Lipkowitz S (2019) Loss of function Cbl-c mutations in solid tumors. PloS One 14:e0219143. https://doi.org/10.1371/journal.pone.0219143 citation_journal_title=Can Res; citation_title=ANXA1 binds and stabilizes EphA2 to promote nasopharyngeal carcinoma growth and metastasis; citation_author=J Feng, SS Lu, T Xiao, W Huang, H Yi, W Zhu, S Fan, XP Feng, JY Li, ZZ Yu; citation_volume=80; citation_publication_date=2020; citation_pages=4386-4398; citation_doi=10.1158/0008-5472.Can-20-0560; citation_id=CR77 citation_journal_title=Mol Cancer; citation_title=The complexity of NF-κB signaling in inflammation and cancer; citation_author=B Hoesel, JA Schmid; citation_volume=12; citation_publication_date=2013; citation_pages=86; citation_doi=10.1186/1476-4598-12-86; citation_id=CR78 citation_journal_title=Genes Dev; citation_title=NF-κB, the first quarter-century: remarkable progress and outstanding questions; citation_author=MS Hayden, S Ghosh; citation_volume=26; citation_publication_date=2012; citation_pages=203-234; citation_doi=10.1101/gad.183434.111; citation_id=CR79 Ngan HL, Wang L, Lo KW, Lui VWY (2018) Genomic landscapes of EBV-associated nasopharyngeal carcinoma vs. HPV-associated head and neck cancer. Cancers 10.  https://doi.org/10.3390/cancers10070210 citation_journal_title=Oncogene; citation_title=The molecular march of primary and recurrent nasopharyngeal carcinoma; citation_author=NJ Campion, M Ally, BJ Jank, J Ahmed, G Alusi; citation_volume=40; citation_publication_date=2021; citation_pages=1757-1774; citation_doi=10.1038/s41388-020-01631-2; citation_id=CR81 Jin X, Ma YC, Zhu WY, Fan L (2019) CUL4A expression is associated with tumor stage and prognosis in nasopharyngeal carcinoma. Medicine 98:e18036.  https://doi.org/10.1097/md.0000000000018036 citation_journal_title=Bioengineered; citation_title=Cullin 4A/protein arginine methyltransferase 5 (CUL4A/PRMT5) promotes cell malignant phenotypes and tumor growth in nasopharyngeal carcinoma; citation_author=X Sun, J Zhou, Z Zhang; citation_volume=13; citation_publication_date=2022; citation_pages=8712-8723; citation_doi=10.1080/21655979.2022.2054756; citation_id=CR83 citation_journal_title=Oncol Rep; citation_title=Protein N-arginine methyltransferase 5 promotes the tumor progression and radioresistance of nasopharyngeal carcinoma; citation_author=D Yang, T Liang, Y Gu, Y Zhao, Y Shi, X Zuo, Q Cao, Y Yang, Q Kan; citation_volume=35; citation_publication_date=2016; citation_pages=1703-1710; citation_doi=10.3892/or.2015.4513; citation_id=CR84 citation_journal_title=Biochem Biophys Res Commun; citation_title=Cloning and characterization of a novel human gene RNF38 encoding a conserved putative protein with a RING finger domain; citation_author=I Eisenberg, H Hochner, T Levi, R Yelin, T Kahan, S Mitrani-Rosenbaum; citation_volume=294; citation_publication_date=2002; citation_pages=1169-1176; citation_doi=10.1016/s0006-291x(02)00584-3; citation_id=CR85 citation_journal_title=J Exp Clin Cancer Res : CR; citation_title=Overexpression of RNF38 facilitates TGF-β signaling by ubiquitinating and degrading AHNAK in hepatocellular carcinoma; citation_author=R Peng, PF Zhang, X Yang, CY Wei, XY Huang, JB Cai, JC Lu, C Gao, HX Sun, Q Gao; citation_volume=38; citation_publication_date=2019; citation_pages=113; citation_doi=10.1186/s13046-019-1113-3; citation_id=CR86 citation_journal_title=Kaohsiung J Med Sci; citation_title=Inhibiting microRNA-301b suppresses cell growth and targets RNF38 in cervical carcinoma; citation_author=WL Guo, N Li, JL Ma, XM Chen, FY Shi; citation_volume=36; citation_publication_date=2020; citation_pages=878-884; citation_doi=10.1002/kjm2.12273; citation_id=CR87 citation_journal_title=Semin Cancer Biol; citation_title=Genetic and epigenetic changes in nasopharyngeal carcinoma; citation_author=KW Lo, DP Huang; citation_volume=12; citation_publication_date=2002; citation_pages=451-462; citation_doi=10.1016/s1044579x02000883; citation_id=CR88 citation_journal_title=J Exp Clin Cancer Res : CR; citation_title=EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways; citation_author=C Lin, J Zong, W Lin, M Wang, Y Xu, R Zhou, S Lin, Q Guo, H Chen, Y Ye; citation_volume=37; citation_publication_date=2018; citation_pages=283; citation_doi=10.1186/s13046-018-0953-6; citation_id=CR89 citation_journal_title=BMC Cancer; citation_title=RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma; citation_author=C Lin, M Li, N Lin, J Zong, J Pan, Y Ye; citation_volume=22; citation_publication_date=2022; citation_pages=549; citation_doi=10.1186/s12885-022-09641-x; citation_id=CR90 citation_journal_title=Nat Rev Immunol; citation_title=A20: linking a complex regulator of ubiquitylation to immunity and human disease; citation_author=A Ma, BA Malynn; citation_volume=12; citation_publication_date=2012; citation_pages=774-785; citation_doi=10.1038/nri3313; citation_id=CR91 citation_journal_title=Adv Exp Med Biol; citation_title=TRAF3 and its biological function; citation_author=JQ He, G Oganesyan, SK Saha, B Zarnegar, G Cheng; citation_volume=597; citation_publication_date=2007; citation_pages=48-59; citation_doi=10.1007/978-0-387-70630-6_4; citation_id=CR92 citation_journal_title=Front Immunol; citation_title=TRAF3 as a multifaceted regulator of B lymphocyte survival and activation; citation_author=GA Bishop, LL Stunz, BS Hostager; citation_volume=9; citation_publication_date=2018; citation_pages=2161; citation_doi=10.3389/fimmu.2018.02161; citation_id=CR93 citation_journal_title=Cell Mol Immunol; citation_title=Regulation of NF-κB signaling by the A20 deubiquitinase; citation_author=N Shembade, EW Harhaj; citation_volume=9; citation_publication_date=2012; citation_pages=123-130; citation_doi=10.1038/cmi.2011.59; citation_id=CR94 citation_journal_title=J Pathol; citation_title=Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma; citation_author=GT Chung, WP Lou, C Chow, KF To, KW Choy, AW Leung, CY Tong, JW Yuen, CW Ko, TT Yip; citation_volume=231; citation_publication_date=2013; citation_pages=311-322; citation_doi=10.1002/path.4239; citation_id=CR95 citation_journal_title=Nat Commun; citation_title=Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations; citation_author=YY Li, GT Chung, VW Lui, KF To, BB Ma, C Chow, JK Woo, KY Yip, J Seo, EP Hui; citation_volume=8; citation_publication_date=2017; citation_pages=14121; citation_doi=10.1038/ncomms14121; citation_id=CR96 Zheng Z, Qu JQ, Yi HM, Ye X, Huang W, Xiao T, Li JY, Wang YY, Feng J, Zhu JF et al (2017) MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway. Cell Death Dis 8:e2855. https://doi.org/10.1038/cddis.2017.211 citation_journal_title=J Cell Physiol; citation_title=Rediscovery of NF-κB signaling in nasopharyngeal carcinoma: how genetic defects of NF-κB pathway interplay with EBV in driving oncogenesis?; citation_author=M Yi, J Cai, J Li, S Chen, Z Zeng, Q Peng, Y Ban, Y Zhou, X Li, W Xiong; citation_volume=233; citation_publication_date=2018; citation_pages=5537-5549; citation_doi=10.1002/jcp.26410; citation_id=CR98 citation_journal_title=Cell; citation_title=Wnt/beta-catenin signaling in development and disease; citation_author=H Clevers; citation_volume=127; citation_publication_date=2006; citation_pages=469-480; citation_doi=10.1016/j.cell.2006.10.018; citation_id=CR99 citation_journal_title=Aging; citation_title=Rab1A promotes cancer metastasis and radioresistance through activating GSK-3β/Wnt/β-catenin signaling in nasopharyngeal carcinoma; citation_author=XZ Yang, XM Chen, LS Zeng, J Deng, L Ma, C Jin, R Wang, MH Wang, YF Wen, XL Wu; citation_volume=12; citation_publication_date=2020; citation_pages=20380-20395; citation_doi=10.18632/aging.103829; citation_id=CR100 citation_journal_title=Yonsei Med J; citation_title=The long noncoding RNA NEAT1 targets miR-34a-5p and drives nasopharyngeal carcinoma progression via Wnt/β-catenin signaling; citation_author=Y Ji, M Wang, X Li, F Cui; citation_volume=60; citation_publication_date=2019; citation_pages=336-345; citation_doi=10.3349/ymj.2019.60.4.336; citation_id=CR101 citation_journal_title=Cell; citation_title=Wnt/β-catenin signaling, disease, and emerging therapeutic modalities; citation_author=R Nusse, H Clevers; citation_volume=169; citation_publication_date=2017; citation_pages=985-999; citation_doi=10.1016/j.cell.2017.05.016; citation_id=CR102 Tsukiyama T, Koo BK, Hatakeyama S (2021) Post-translational Wnt receptor regulation: is the fog slowly clearing?: the molecular mechanism of RNF43/ZNRF3 ubiquitin ligases is not yet fully elucidated and still controversial. BioEssays: news and reviews in molecular, cellular and developmental biology 43:e2000297. https://doi.org/10.1002/bies.202000297 citation_journal_title=J Bioenerg Biomembr; citation_title=Nucleolar and spindle-associated protein 1 accelerates cellular proliferation and invasion in nasopharyngeal carcinoma by potentiating Wnt/β-catenin signaling via modulation of GSK-3β; citation_author=L Zhang, Y Dang, Y Wang, X Fan; citation_volume=52; citation_publication_date=2020; citation_pages=441-451; citation_doi=10.1007/s10863-020-09860-6; citation_id=CR104 citation_journal_title=Nat Rev Cancer; citation_title=Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer; citation_author=D Frescas, M Pagano; citation_volume=8; citation_publication_date=2008; citation_pages=438-449; citation_doi=10.1038/nrc2396; citation_id=CR105 citation_journal_title=Oncogene; citation_title=β-Trcp and CK1δ-mediated degradation of LZTS2 activates PI3K/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma; citation_author=Y Lu, X Li, H Liu, J Xue, Z Zeng, X Dong, T Zhang, G Wu, K Yang, S Xu; citation_volume=40; citation_publication_date=2021; citation_pages=1269-1283; citation_doi=10.1038/s41388-020-01596-2; citation_id=CR106 Shi H, Sun Y, Ruan H, Ji C, Zhang J, Wu P, Li L, Huang C, Jia Y, Zhang X et al (2021) 3,3′-Diindolylmethane promotes gastric cancer progression via β-TrCP-mediated NF-κB activation in gastric cancer-derived MSCs. Front Oncol 11:603533. https://doi.org/10.3389/fonc.2021.603533 citation_journal_title=Cell Death Dis; citation_title=Aspirin attenuates YAP and β-catenin expression by promoting β-TrCP to overcome docetaxel and vinorelbine resistance in triple-negative breast cancer; citation_author=J Ma, Z Fan, Q Tang, H Xia, T Zhang, F Bi; citation_volume=11; citation_publication_date=2020; citation_pages=530; citation_doi=10.1038/s41419-020-2719-2; citation_id=CR108 citation_journal_title=Oncotarget; citation_title=EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC; citation_author=Q Yan, Z Zeng, Z Gong, W Zhang, X Li, B He, Y Song, Q Li, Y Zeng, Q Liao; citation_volume=6; citation_publication_date=2015; citation_pages=41766-41782; citation_doi=10.18632/oncotarget.6155; citation_id=CR109 citation_journal_title=Mol Cancer; citation_title=Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop; citation_author=Y Mo, Y Wang, Y Wang, X Deng, Q Yan, C Fan, S Zhang, S Zhang, Z Gong, L Shi; citation_volume=21; citation_publication_date=2022; citation_pages=192; citation_doi=10.1186/s12943-022-01659-w; citation_id=CR110 citation_journal_title=Biol Cell; citation_title=TRIM family proteins: emerging class of RING E3 ligases as regulator of NF-κB pathway; citation_author=D Tomar, R Singh; citation_volume=107; citation_publication_date=2015; citation_pages=22-40; citation_doi=10.1111/boc.201400046; citation_id=CR111 citation_journal_title=Front Cell Dev Biol; citation_title=Emerging roles of tripartite motif-containing family proteins (TRIMs) in eliminating misfolded proteins; citation_author=L Zhang, LO Afolabi, X Wan, Y Li, L Chen; citation_volume=8; citation_publication_date=2020; citation_pages=802; citation_doi=10.3389/fcell.2020.00802; citation_id=CR112 citation_journal_title=Biochem Biophys Res Commun; citation_title=Trim11 increases expression of dopamine beta-hydroxylase gene by interacting with Phox2b; citation_author=SJ Hong, H Chae, T Lardaro, S Hong, KS Kim; citation_volume=368; citation_publication_date=2008; citation_pages=650-655; citation_doi=10.1016/j.bbrc.2008.01.165; citation_id=CR113 citation_journal_title=Cell Rep; citation_title=Enhanced degradation of misfolded proteins promotes tumorigenesis; citation_author=L Chen, MD Brewer, L Guo, R Wang, P Jiang, X Yang; citation_volume=18; citation_publication_date=2017; citation_pages=3143-3154; citation_doi=10.1016/j.celrep.2017.03.010; citation_id=CR114 citation_journal_title=Oncogenesis; citation_title=TRIM11 facilitates chemoresistance in nasopharyngeal carcinoma by activating the β-catenin/ABCC9 axis via p62-selective autophagic degradation of Daple; citation_author=R Zhang, SW Li, L Liu, J Yang, G Huang, Y Sang; citation_volume=9; citation_publication_date=2020; citation_pages=45; citation_doi=10.1038/s41389-020-0229-9; citation_id=CR115 citation_journal_title=Biochem Biophys Res Commun; citation_title=The Daple-CK1ε complex regulates Dvl2 phosphorylation and canonical Wnt signaling; citation_author=N Esaki, A Enomoto, M Takagishi, Y Mizutani, T Iida, K Ushida, Y Shiraki, S Mii, M Takahashi; citation_volume=532; citation_publication_date=2020; citation_pages=406-413; citation_doi=10.1016/j.bbrc.2020.08.066; citation_id=CR116 Begicevic RR, Falasca M (2017) ABC transporters in cancer stem cells: beyond chemoresistance. Int J Mol Sci 18. https://doi.org/10.3390/ijms18112362 Hao HX, Jiang X, Cong F (2016) Control of Wnt receptor turnover by R-spondin-ZNRF3/RNF43 signaling module and its dysregulation in cancer. Cancers 8. https://doi.org/10.3390/cancers8060054 citation_journal_title=Cell Biochem Biophys; citation_title=ZnRF3 Induces Apoptosis of gastric cancer cells by antagonizing Wnt and Hedgehog signaling; citation_author=H Qin, A Cai, H Xi, J Yuan, L Chen; citation_volume=73; citation_publication_date=2015; citation_pages=361-367; citation_doi=10.1007/s12013-015-0607-7; citation_id=CR119 citation_journal_title=Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine; citation_title=ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells; citation_author=W Qiu, Z Yang, Y Fan, Q Zheng; citation_volume=37; citation_publication_date=2016; citation_pages=12665-12672; citation_doi=10.1007/s13277-016-5250-4; citation_id=CR120 citation_journal_title=Oncol Res; citation_title=ZNRF3 inhibits the invasion and tumorigenesis in nasopharyngeal carcinoma cells by inactivating the Wnt/β-catenin pathway; citation_author=Z Wang, Y Wang, H Ren, Y Jin, Y Guo; citation_volume=25; citation_publication_date=2017; citation_pages=571-577; citation_doi=10.3727/97818823455816x14760478220149; citation_id=CR121 Wang Z, Wang Y, Ma X, Dang C (2021) RSPO2 silence inhibits tumorigenesis of nasopharyngeal carcinoma by ZNRF3/Hedgehog-Gli1 signal pathway. Life Sci 282:119817.  https://doi.org/10.1016/j.lfs.2021.119817 citation_journal_title=Mol Pharmacol; citation_title=Hypoxia-inducible factor-1 (HIF-1); citation_author=Q Ke, M Costa; citation_volume=70; citation_publication_date=2006; citation_pages=1469-1480; citation_doi=10.1124/mol.106.027029; citation_id=CR123 citation_journal_title=Cell; citation_title=C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation; citation_author=AC Epstein, JM Gleadle, LA McNeill, KS Hewitson, J O'Rourke, DR Mole, M Mukherji, E Metzen, MI Wilson, A Dhanda; citation_volume=107; citation_publication_date=2001; citation_pages=43-54; citation_doi=10.1016/s0092-8674(01)00507-4; citation_id=CR124 citation_journal_title=Annu Rev Cell Dev Biol; citation_title=Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1; citation_author=GL Semenza; citation_volume=15; citation_publication_date=1999; citation_pages=551-578; citation_doi=10.1146/annurev.cellbio.15.1.551; citation_id=CR125 citation_journal_title=J Biol Chem; citation_title=Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor; citation_author=RJ Appelhoff, YM Tian, RR Raval, H Turley, AL Harris, CW Pugh, PJ Ratcliffe, JM Gleadle; citation_volume=279; citation_publication_date=2004; citation_pages=38458-38465; citation_doi=10.1074/jbc.M406026200; citation_id=CR126 citation_journal_title=Saudi Med J; citation_title=Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma; citation_author=Z Chen, XH Xu; citation_volume=36; citation_publication_date=2015; citation_pages=659-664; citation_doi=10.15537/smj.2015.6.11460; citation_id=CR127 citation_journal_title=Nat Commun; citation_title=Vasculogenic mimicry formation in EBV-associated epithelial malignancies; citation_author=T Xiang, YX Lin, W Ma, HJ Zhang, KM Chen, GP He, X Zhang, M Xu, QS Feng, MY Chen; citation_volume=9; citation_publication_date=2018; citation_pages=5009; citation_doi=10.1038/s41467-018-07308-5; citation_id=CR128 citation_journal_title=Development (Cambridge, England); citation_title=Isolation and characterisation of murine homologues of the Drosophila seven in absentia gene (sina); citation_author=NG Della, PV Senior, DD Bowtell; citation_volume=117; citation_publication_date=1993; citation_pages=1333-1343; citation_doi=10.1242/dev.117.4.1333; citation_id=CR129 Gopalsamy A, Hagen T, Swaminathan K (2014) Investigating the molecular basis of Siah1 and Siah2 E3 ubiquitin ligase substrate specificity. PloS One 9:e106547. https://doi.org/10.1371/journal.pone.0106547 citation_journal_title=Can Res; citation_title=EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells; citation_author=S Kondo, SY Seo, T Yoshizaki, N Wakisaka, M Furukawa, I Joab, KL Jang, JS Pagano; citation_volume=66; citation_publication_date=2006; citation_pages=9870-9877; citation_doi=10.1158/0008-5472.Can-06-1679; citation_id=CR131 citation_journal_title=Cancer Lett; citation_title=Expression of seven-in-absentia homologue 1 and hypoxia-inducible factor 1 alpha: novel prognostic factors of nasopharyngeal carcinoma; citation_author=N Kitagawa, S Kondo, N Wakisaka, Y Zen, Y Nakanishi, A Tsuji, K Endo, S Murono, T Yoshizaki; citation_volume=331; citation_publication_date=2013; citation_pages=52-57; citation_doi=10.1016/j.canlet.2012.12.002; citation_id=CR132 citation_journal_title=Oncogene; citation_title=Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes; citation_author=M Aga, GL Bentz, S Raffa, MR Torrisi, S Kondo, N Wakisaka, T Yoshizaki, JS Pagano, J Shackelford; citation_volume=33; citation_publication_date=2014; citation_pages=4613-4622; citation_doi=10.1038/onc.2014.66; citation_id=CR133 citation_journal_title=Mol Ther Nucleic Acids; citation_title=miR-144 delivered by nasopharyngeal carcinoma-derived EVs stimulates angiogenesis through the FBXW7/HIF-1α/VEGF-A axis; citation_author=X Tian, Y Liu, Z Wang, S Wu; citation_volume=24; citation_publication_date=2021; citation_pages=1000-1011; citation_doi=10.1016/j.omtn.2021.03.016; citation_id=CR134 citation_journal_title=Cell; citation_title=The p53 proto-oncogene can act as a suppressor of transformation; citation_author=CA Finlay, PW Hinds, AJ Levine; citation_volume=57; citation_publication_date=1989; citation_pages=1083-1093; citation_doi=10.1016/0092-8674(89)90045-7; citation_id=CR135 citation_journal_title=Nat Rev Cancer; citation_title=Awakening guardian angels: drugging the p53 pathway; citation_author=CJ Brown, S Lain, CS Verma, AR Fersht, DP Lane; citation_volume=9; citation_publication_date=2009; citation_pages=862-873; citation_doi=10.1038/nrc2763; citation_id=CR136 citation_journal_title=Cell Death Differ; citation_title=Mutant p53 partners in crime; citation_author=MP Kim, G Lozano; citation_volume=25; citation_publication_date=2018; citation_pages=161-168; citation_doi=10.1038/cdd.2017.185; citation_id=CR137 citation_journal_title=Nat Rev Mol Cell Biol; citation_title=p53 in health and disease; citation_author=KH Vousden, DP Lane; citation_volume=8; citation_publication_date=2007; citation_pages=275-283; citation_doi=10.1038/nrm2147; citation_id=CR138 citation_journal_title=Proc Natl Acad Sci USA; citation_title=An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma; citation_author=Y Sun, G Hegamyer, YJ Cheng, A Hildesheim, JY Chen, IH Chen, Y Cao, KT Yao, NH Colburn; citation_volume=89; citation_publication_date=1992; citation_pages=6516-6520; citation_doi=10.1073/pnas.89.14.6516; citation_id=CR139 citation_journal_title=Pathol Int; citation_title=Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells; citation_author=LF Sheu, A Chen, HS Lee, HY Hsu, DS Yu; citation_volume=54; citation_publication_date=2004; citation_pages=475-485; citation_doi=10.1111/j.1440-1827.2004.01654.x; citation_id=CR140 citation_journal_title=Laryngoscope; citation_title=A lack of association between p53 mutations and recurrent nasopharyngeal carcinomas refractory to radiotherapy; citation_author=KP Chang, SP Hao, SY Lin, KC Tsao, TT Kuo, MH Tsai, CK Tseng, NM Tsang; citation_volume=112; citation_publication_date=2002; citation_pages=2015-2019; citation_doi=10.1097/00005537-200211000-00019; citation_id=CR141 citation_journal_title=Cell cycle (Georgetown, Tex); citation_title=Viral oncoprotein LMP1 disrupts p53-induced cell cycle arrest and apoptosis through modulating K63-linked ubiquitination of p53; citation_author=L Li, W Li, L Xiao, J Xu, X Chen, M Tang, Z Dong, Q Tao, Y Cao; citation_volume=11; citation_publication_date=2012; citation_pages=2327-2336; citation_doi=10.4161/cc.20771; citation_id=CR142 citation_journal_title=Mini Rev Med Chem; citation_title=Nutlin-3, A p53-Mdm2 antagonist for nasopharyngeal carcinoma treatment; citation_author=V Yee-Lin, W Pooi-Fong, AK Soo-Beng; citation_volume=18; citation_publication_date=2018; citation_pages=173-183; citation_doi=10.2174/1389557517666170717125821; citation_id=CR143 citation_journal_title=J Biomed Sci; citation_title=TRIM21-SERPINB5 aids GMPS repression to protect nasopharyngeal carcinoma cells from radiation-induced apoptosis; citation_author=P Zhang, X Li, Q He, L Zhang, K Song, X Yang, Q He, Y Wang, X Hong, J Ma; citation_volume=27; citation_publication_date=2020; citation_pages=30; citation_doi=10.1186/s12929-020-0625-7; citation_id=CR144 citation_journal_title=Acta Biochim Biophys Sin; citation_title=The regulation of MDM2 oncogene and its impact on human cancers; citation_author=Y Zhao, H Yu, W Hu; citation_volume=46; citation_publication_date=2014; citation_pages=180-189; citation_doi=10.1093/abbs/gmt147; citation_id=CR145 citation_journal_title=Annu Rev Pathol; citation_title=The roles of MDM2 and MDMX in cancer; citation_author=O Karni-Schmidt, M Lokshin, C Prives; citation_volume=11; citation_publication_date=2016; citation_pages=617-644; citation_doi=10.1146/annurev-pathol-012414-040349; citation_id=CR146 citation_journal_title=J Cell Physiol; citation_title=Regulation of MDM2 stability after DNA damage; citation_author=J Li, M Kurokawa; citation_volume=230; citation_publication_date=2015; citation_pages=2318-2327; citation_doi=10.1002/jcp.24994; citation_id=CR147 citation_journal_title=Oncol Lett; citation_title=p53, MDM2, eIF4E and EGFR expression in nasopharyngeal carcinoma and their correlation with clinicopathological characteristics and prognosis: a retrospective study; citation_author=P Zhang, SK Wu, Y Wang, ZX Fan, CR Li, M Feng, P Xu, WD Wang, JY Lang; citation_volume=9; citation_publication_date=2015; citation_pages=113-118; citation_doi=10.3892/ol.2014.2631; citation_id=CR148 citation_journal_title=Onkologie; citation_title=The MDM2 309 T/G polymorphism is associated with head and neck cancer risk especially in nasopharyngeal cancer: a meta-analysis; citation_author=Y Zhang, Y Bai, Y Zhang, J Guan, L Chen; citation_volume=35; citation_publication_date=2012; citation_pages=666-670; citation_doi=10.1159/000343639; citation_id=CR149 citation_journal_title=Mol Carcinog; citation_title=Role of the MDM2 SNP309 polymorphism in the initiation and early age of onset of nasopharyngeal carcinoma; citation_author=H Sousa, M Pando, E Breda, R Catarino, R Medeiros; citation_volume=50; citation_publication_date=2011; citation_pages=73-79; citation_doi=10.1002/mc.20689; citation_id=CR150 citation_journal_title=J Cancer; citation_title=Cell proliferation and invasion is promoted by circSERPINA3 in nasopharyngeal carcinoma by regulating miR-944/MDM2 axis; citation_author=R Liu, M Zhou, P Zhang, Y Zhao, Y Zhang; citation_volume=11; citation_publication_date=2020; citation_pages=3910-3918; citation_doi=10.7150/jca.42799; citation_id=CR151 citation_journal_title=Am J Pathol; citation_title=NOLC1, an enhancer of nasopharyngeal carcinoma progression, is essential for TP53 to regulate MDM2 expression; citation_author=YC Hwang, TY Lu, DY Huang, YS Kuo, CF Kao, NH Yeh, HC Wu, CT Lin; citation_volume=175; citation_publication_date=2009; citation_pages=342-354; citation_doi=10.2353/ajpath.2009.080931; citation_id=CR152 citation_journal_title=Nat Rev Immunol; citation_title=TRIM family proteins and their emerging roles in innate immunity; citation_author=K Ozato, DM Shin, TH Chang, HC Morse; citation_volume=8; citation_publication_date=2008; citation_pages=849-860; citation_doi=10.1038/nri2413; citation_id=CR153 citation_journal_title=Mol Cell; citation_title=Nucleotide biosynthetic enzyme GMP synthase is a TRIM21-controlled relay of p53 stabilization; citation_author=BA Reddy, JA Knaap, AG Bot, A Mohd-Sarip, DH Dekkers, MA Timmermans, JW Martens, JA Demmers, CP Verrijzer; citation_volume=53; citation_publication_date=2014; citation_pages=458-470; citation_doi=10.1016/j.molcel.2013.12.017; citation_id=CR154 citation_journal_title=Can Res; citation_title=Hypermethylation of SHISA3 promotes nasopharyngeal carcinoma metastasis by reducing SGSM1 stability; citation_author=J Zhang, YQ Li, R Guo, YQ Wang, PP Zhang, XR Tang, X Wen, XH Hong, Y Lei, QM He; citation_volume=79; citation_publication_date=2019; citation_pages=747-759; citation_doi=10.1158/0008-5472.Can-18-1754; citation_id=CR155 citation_journal_title=Oncogene; citation_title=LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-κB activity in nasopharyngeal carcinoma; citation_author=H Wang, Y Zhou, L Oyang, Y Han, L Xia, J Lin, Y Tang, M Su, S Tan, Y Tian; citation_volume=38; citation_publication_date=2019; citation_pages=5062-5075; citation_doi=10.1038/s41388-019-0778-6; citation_id=CR156 Zhao Y, Li WF, Li QJ, He SW, He QM, Long LF, Liu N, Ma J (2021) WIPI-1 inhibits metastasis and tumour growth via the WIPI-1-TRIM21 axis and MYC regulation in nasopharyngeal carcinoma. Oral Oncol 122:105576. https://doi.org/10.1016/j.oraloncology.2021.105576 Qi YF, Liu M, Zhang Y, Liu W, Xiao H, Luo B (2019) EBV down-regulates COX-2 expression via TRAF2 and ERK signal pathway in EBV-associated gastric cancer. Virus Res 272:197735.  https://doi.org/10.1016/j.virusres.2019.197735 citation_journal_title=Blood; citation_title=EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression; citation_author=I Guasparri, D Bubman, E Cesarman; citation_volume=111; citation_publication_date=2008; citation_pages=3813-3820; citation_doi=10.1182/blood-2007-03-080309; citation_id=CR159 citation_journal_title=J Virol; citation_title=The Epstein-Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2- and p53-dependent manner; citation_author=SR Hagemeier, EA Barlow, AA Kleman, SC Kenney; citation_volume=85; citation_publication_date=2011; citation_pages=4318-4329; citation_doi=10.1128/jvi.01856-10; citation_id=CR160 citation_journal_title=Biomed Res Int; citation_title=TRAF2 knockdown in nasopharyngeal carcinoma induced cell cycle arrest and enhanced the sensitivity to radiotherapy; citation_author=H Zhu, W Ding, J Wu, R Ma, Z Pan, X Mao; citation_volume=2020; citation_publication_date=2020; citation_pages=1641340; citation_doi=10.1155/2020/1641340; citation_id=CR161 citation_journal_title=J Transl Med; citation_title=Haplotype of gene Nedd4 binding protein 2 associated with sporadic nasopharyngeal carcinoma in the Southern Chinese population; citation_author=MZ Zheng, HD Qin, XJ Yu, RH Zhang, LZ Chen, QS Feng, YX Zeng; citation_volume=5; citation_publication_date=2007; citation_pages=36; citation_doi=10.1186/1479-5876-5-36; citation_id=CR162 citation_journal_title=Cell cycle (Georgetown, Tex); citation_title=NEDD4 is involved in acquisition of epithelial-mesenchymal transition in cisplatin-resistant nasopharyngeal carcinoma cells; citation_author=S Feng, G Yang, H Yang, Z Liang, R Zhang, Y Fan, G Zhang; citation_volume=16; citation_publication_date=2017; citation_pages=869-878; citation_doi=10.1080/15384101.2017.1308617; citation_id=CR163 citation_journal_title=J Biol Chem; citation_title=Interaction between two ubiquitin-protein isopeptide ligases of different classes, CBLC and AIP4/ITCH; citation_author=JR Courbard, F Fiore, J Adélaïde, JP Borg, D Birnbaum, V Ollendorff; citation_volume=277; citation_publication_date=2002; citation_pages=45267-45275; citation_doi=10.1074/jbc.M206460200; citation_id=CR164 citation_journal_title=Immunol Res; citation_title=Cbl- and Nedd4-family ubiquitin ligases: balancing tolerance and immunity; citation_author=DL Gay, H Ramón, PM Oliver; citation_volume=42; citation_publication_date=2008; citation_pages=51-64; citation_doi=10.1007/s12026-008-8034-0; citation_id=CR165 citation_journal_title=Sci Rep; citation_title=Degradation of cofilin is regulated by Cbl, AIP4 and Syk resulting in increased migration of LMP2A positive nasopharyngeal carcinoma cells; citation_author=MR Gainullin, IY Zhukov, X Zhou, Y Mo, L Astakhova, I Ernberg, L Matskova; citation_volume=7; citation_publication_date=2017; citation_pages=9012; citation_doi=10.1038/s41598-017-09540-3; citation_id=CR166 Xu J, Huang Y, Zhao J, Wu L, Qi Q, Liu Y, Li G, Li J, Liu H, Wu H (2021) Cofilin: a promising protein implicated in cancer metastasis and apoptosis. Front Cell Dev Biol 9:599065. https://doi.org/10.3389/fcell.2021.599065 Wang L, Sang J, Zhang Y, Gao L, Zhao D, Cao H (2022) Circular RNA ITCH attenuates the progression of nasopharyngeal carcinoma by inducing PTEN upregulation via miR-214. J Genet Med 24:e3391.  https://doi.org/10.1002/jgm.3391 citation_journal_title=J Clin Oncol: Official J Am Soc Clin Oncol; citation_title=Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies; citation_author=RZ Orlowski, TE Stinchcombe, BS Mitchell, TC Shea, AS Baldwin, S Stahl, J Adams, DL Esseltine, PJ Elliott, CS Pien; citation_volume=20; citation_publication_date=2002; citation_pages=4420-4427; citation_doi=10.1200/jco.2002.01.133; citation_id=CR169 citation_journal_title=Curr Cancer Drug Targets; citation_title=Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system; citation_author=QP Dou, JA Zonder; citation_volume=14; citation_publication_date=2014; citation_pages=517-536; citation_doi=10.2174/1568009614666140804154511; citation_id=CR170 citation_journal_title=Cancer Immunol Res; citation_title=Bortezomib relieves immune tolerance in nasopharyngeal carcinoma via STAT1 suppression and indoleamine 2,3-dioxygenase downregulation; citation_author=GM Jiang, HS Wang, J Du, WF Ma, H Wang, Y Qiu, QG Zhang, W Xu, HF Liu, JP Liang; citation_volume=5; citation_publication_date=2017; citation_pages=42-51; citation_doi=10.1158/2326-6066.Cir-16-0102; citation_id=CR171 citation_journal_title=Mol Cancer Ther; citation_title=Bortezomib and SAHA synergistically induce ROS-driven caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein-Barr virus; citation_author=KF Hui, BH Lam, DN Ho, SW Tsao, AK Chiang; citation_volume=12; citation_publication_date=2013; citation_pages=747-758; citation_doi=10.1158/1535-7163.Mct-12-0811; citation_id=CR172 citation_journal_title=Int J Cancer; citation_title=Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism; citation_author=KF Hui, AK Chiang; citation_volume=135; citation_publication_date=2014; citation_pages=2950-2961; citation_doi=10.1002/ijc.28924; citation_id=CR173 Hu L, Pan X, Hu J, Zeng H, Liu X, Jiang M, Jiang B (2021) Proteasome inhibitors decrease paclitaxel‑induced cell death in nasopharyngeal carcinoma with the accumulation of CDK1/cyclin B1. Int J Mol Med 48. https://doi.org/10.3892/ijmm.2021.5026 citation_journal_title=Sci Rep; citation_title=Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells; citation_author=M Benvenuto, S Ciuffa, C Focaccetti, D Sbardella, S Fazi, M Scimeca, GR Tundo, G Barillari, M Segni, E Bonanno; citation_volume=11; citation_publication_date=2021; citation_pages=19051; citation_doi=10.1038/s41598-021-98450-6; citation_id=CR175 citation_journal_title=Head Neck; citation_title=Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): a trial of the Eastern Cooperative Oncology Group; citation_author=J Gilbert, JW Lee, A Argiris, M Haigentz, LE Feldman, M Jang, P Arun, C Waes, AA Forastiere; citation_volume=35; citation_publication_date=2013; citation_pages=942-948; citation_doi=10.1002/hed.23046; citation_id=CR176 citation_journal_title=Leukemia; citation_title=MDM2 inhibition: an important step forward in cancer therapy; citation_author=M Konopleva, G Martinelli, N Daver, C Papayannidis, A Wei, B Higgins, M Ott, J Mascarenhas, M Andreeff; citation_volume=34; citation_publication_date=2020; citation_pages=2858-2874; citation_doi=10.1038/s41375-020-0949-z; citation_id=CR177 citation_journal_title=Curr Med Chem; citation_title=Molecular modeling approaches in the discovery of new drugs for anti-cancer therapy: the investigation of p53-MDM2 interaction and its inhibition by small molecules; citation_author=A Lauria, M Tutone, M Ippolito, L Pantano, AM Almerico; citation_volume=17; citation_publication_date=2010; citation_pages=3142-3154; citation_doi=10.2174/092986710792232021; citation_id=CR178 citation_journal_title=Science (New York, NY); citation_title=In vivo activation of the p53 pathway by small-molecule antagonists of MDM2; citation_author=LT Vassilev, BT Vu, B Graves, D Carvajal, F Podlaski, Z Filipovic, N Kong, U Kammlott, C Lukacs, C Klein; citation_volume=303; citation_publication_date=2004; citation_pages=844-848; citation_doi=10.1126/science.1092472; citation_id=CR179 citation_journal_title=Oncol Rep; citation_title=Nutlin-3 sensitizes nasopharyngeal carcinoma cells to cisplatin-induced cytotoxicity; citation_author=YL Voon, M Ahmad, PF Wong, R Husaini, WT Ng, CO Leong, DP Lane, AS Khoo; citation_volume=34; citation_publication_date=2015; citation_pages=1692-1700; citation_doi=10.3892/or.2015.4177; citation_id=CR180 citation_journal_title=Oncotarget; citation_title=Inhibition of histone deacetylases induces formation of multipolar spindles and subsequent p53-dependent apoptosis in nasopharyngeal carcinoma cells; citation_author=M Yan, YM Qian, CF Yue, ZF Wang, BC Wang, W Zhang, FM Zheng, Q Liu; citation_volume=7; citation_publication_date=2016; citation_pages=44171-44184; citation_doi=10.18632/oncotarget.9922; citation_id=CR181 citation_journal_title=J Med Chem; citation_title=Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development; citation_author=Q Ding, Z Zhang, JJ Liu, N Jiang, J Zhang, TM Ross, XJ Chu, D Bartkovitz, F Podlaski, C Janson; citation_volume=56; citation_publication_date=2013; citation_pages=5979-5983; citation_doi=10.1021/jm400487c; citation_id=CR182 citation_journal_title=Oncotarget; citation_title=Combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer; citation_author=M Zanjirband, N Curtin, RJ Edmondson, J Lunec; citation_volume=8; citation_publication_date=2017; citation_pages=69779-69796; citation_doi=10.18632/oncotarget.19266; citation_id=CR183 citation_journal_title=Oncotarget; citation_title=Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma; citation_author=L Chen, RF Rousseau, SA Middleton, GL Nichols, DR Newell, J Lunec, DA Tweddle; citation_volume=6; citation_publication_date=2015; citation_pages=10207-10221; citation_doi=10.18632/oncotarget.3504; citation_id=CR184 citation_journal_title=Onco Targets Ther; citation_title=MDM2 antagonists as a novel treatment option for acute myeloid leukemia: perspectives on the therapeutic potential of idasanutlin (RG7388); citation_author=A Khurana, DA Shafer; citation_volume=12; citation_publication_date=2019; citation_pages=2903-2910; citation_doi=10.2147/ott.S172315; citation_id=CR185 citation_journal_title=Cancer Biol Ther; citation_title=MDM2 inhibitor RG7388 potently inhibits tumors by activating p53 pathway in nasopharyngeal carcinoma; citation_author=X Fan, Y Wang, J Song, H Wu, M Yang, L Lu, X Weng, L Liu, G Nie; citation_volume=20; citation_publication_date=2019; citation_pages=1328-1336; citation_doi=10.1080/15384047.2019.1638677; citation_id=CR186 citation_journal_title=Am J Transl Res; citation_title=Paeoniflorin exhibits antitumor effects in nasopharyngeal carcinoma cells through downregulation of NEDD4; citation_author=Y Chen, R Zhang, W Zhao, M Lv, M Chen, Y Yan, S Feng; citation_volume=11; citation_publication_date=2019; citation_pages=7579-7590; citation_id=CR187 citation_journal_title=Cancer Lett; citation_title=Chemically synthesized cinobufagin suppresses nasopharyngeal carcinoma metastasis by inducing ENKUR to stabilize p53 expression; citation_author=R Hou, X Liu, H Yang, S Deng, C Cheng, J Liu, Y Li, Y Zhang, J Jiang, Z Zhu; citation_volume=531; citation_publication_date=2022; citation_pages=57-70; citation_doi=10.1016/j.canlet.2022.01.025; citation_id=CR188 citation_journal_title=Biomed Res Int; citation_title=Curcumin inhibits proliferation of Epstein-Barr virus-associated human nasopharyngeal carcinoma cells by inhibiting EBV nuclear antigen 1 expression; citation_author=L Liu, J Yang, W Ji, C Wang; citation_volume=2019; citation_publication_date=2019; citation_pages=8592921; citation_doi=10.1155/2019/8592921; citation_id=CR189 citation_journal_title=J Hematol Oncol; citation_title=Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy; citation_author=X Li, Y Song; citation_volume=13; citation_publication_date=2020; citation_pages=50; citation_doi=10.1186/s13045-020-00885-3; citation_id=CR190 citation_journal_title=Nat Med; citation_title=A selective BCL-X(L) PROTAC degrader achieves safe and potent antitumor activity; citation_author=S Khan, X Zhang, D Lv, Q Zhang, Y He, P Zhang, X Liu, D Thummuri, Y Yuan, JS Wiegand; citation_volume=25; citation_publication_date=2019; citation_pages=1938-1947; citation_doi=10.1038/s41591-019-0668-z; citation_id=CR191 citation_journal_title=J Med Chem; citation_title=Discovery of SIAIS178 as an effective BCR-ABL degrader by recruiting Von Hippel-Lindau (VHL) E3 ubiquitin ligase; citation_author=Q Zhao, C Ren, L Liu, J Chen, Y Shao, N Sun, R Sun, Y Kong, X Ding, X Zhang; citation_volume=62; citation_publication_date=2019; citation_pages=9281-9298; citation_doi=10.1021/acs.jmedchem.9b01264; citation_id=CR192 Shi S, Du Y, Huang L, Cui J, Niu J, Xu Y, Zhu Q (2022) Discovery of novel potent covalent inhibitor-based EGFR degrader with excellent in vivo efficacy. Bioorg Chem 120:105605. https://doi.org/10.1016/j.bioorg.2022.105605 Zeng S, Huang W, Zheng X, Liyan C, Zhang Z, Wang J, Shen Z (2021) Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: recent progress and future challenges. Eur J Med Chem 210:112981. https://doi.org/10.1016/j.ejmech.2020.112981 citation_journal_title=Signal Transduct Target Ther; citation_title=Targeted protein degradation: mechanisms, strategies and application; citation_author=L Zhao, J Zhao, K Zhong, A Tong, D Jia; citation_volume=7; citation_publication_date=2022; citation_pages=113; citation_doi=10.1038/s41392-022-00966-4; citation_id=CR195 citation_journal_title=Curr Med Chem; citation_title=Targeted protein degradation and regulation with molecular glue: past and recent discoveries; citation_author=Y Fang, Q He, J Cao; citation_volume=29; citation_publication_date=2022; citation_pages=2490-2503; citation_doi=10.2174/0929867328666210806113949; citation_id=CR196 citation_journal_title=Pharmacol Ther; citation_title=Molecular mechanisms of cereblon-based drugs; citation_author=T Asatsuma-Okumura, T Ito, H Handa; citation_volume=202; citation_publication_date=2019; citation_pages=132-139; citation_doi=10.1016/j.pharmthera.2019.06.004; citation_id=CR197 citation_journal_title=Cancer; citation_title=Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: a multicenter, open-label, randomized controlled trial; citation_author=L Liang, Z Liu, H Zhu, H Wang, Y Wei, X Ning, Z Shi, L Jiang, Z Lin, H Yan; citation_volume=128; citation_publication_date=2022; citation_pages=1467-1474; citation_doi=10.1002/cncr.34074; citation_id=CR198 citation_journal_title=Int J Clin Exp Pathol; citation_title=A rare case of nasopharyngeal carcinoma in a patient with multiple myeloma after treatment by lenalidomide; citation_author=G Xu, B Wang, M Yang, W Qian; citation_volume=8; citation_publication_date=2015; citation_pages=15025-15029; citation_id=CR199 citation_journal_title=Blood; citation_title=CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells; citation_author=C Surka, L Jin, N Mbong, CC Lu, IS Jang, E Rychak, D Mendy, T Clayton, E Tindall, C Hsu; citation_volume=137; citation_publication_date=2021; citation_pages=661-677; citation_doi=10.1182/blood.2020008676; citation_id=CR200 citation_journal_title=Am J Cancer Res; citation_title=The regulatory network of nasopharyngeal carcinoma metastasis with a focus on EBV, lncRNAs and miRNAs; citation_author=CX Zhao, W Zhu, ZQ Ba, HJ Xu, WD Liu, B Zhu, L Wang, YJ Song, S Yuan, CP Ren; citation_volume=8; citation_publication_date=2018; citation_pages=2185-2209; citation_id=CR201 citation_journal_title=Signal Transduct Target Ther; citation_title=Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma; citation_author=Y Kang, W He, C Ren, J Qiao, Q Guo, J Hu, H Xu, X Jiang, L Wang; citation_volume=5; citation_publication_date=2020; citation_pages=245; citation_doi=10.1038/s41392-020-00340-2; citation_id=CR202 citation_journal_title=Signal Transduct Target Ther; citation_title=Chemical compound cinobufotalin potently induces FOXO1-stimulated cisplatin sensitivity by antagonizing its binding partner MYH9; citation_author=Y Li, X Liu, X Lin, M Zhao, Y Xiao, C Liu, Z Liang, Z Lin, R Yi, Z Tang; citation_volume=4; citation_publication_date=2019; citation_pages=48; citation_doi=10.1038/s41392-019-0084-3; citation_id=CR203 citation_journal_title=Cell Death Dis; citation_title=LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN; citation_author=Q Gao, L Tang, L Wu, K Li, H Wang, W Li, J Wu, M Li, S Wang, L Zhao; citation_volume=9; citation_publication_date=2018; citation_pages=393; citation_doi=10.1038/s41419-018-0443-y; citation_id=CR204 citation_journal_title=Oncotarget; citation_title=TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation; citation_author=CJ Drummond, A Esfandiari, J Liu, X Lu, C Hutton, J Jackson, K Bennaceur, Q Xu, AR Makimanejavali, F Bello; citation_volume=7; citation_publication_date=2016; citation_pages=46203-46218; citation_doi=10.18632/oncotarget.10073; citation_id=CR205 citation_journal_title=J Hematol Oncol; citation_title=MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer; citation_author=V Tisato, R Voltan, A Gonelli, P Secchiero, G Zauli; citation_volume=10; citation_publication_date=2017; citation_pages=133; citation_doi=10.1186/s13045-017-0500-5; citation_id=CR206 Anwar Z, Ali MS, Galvano A, Perez A, La Mantia M, Bukhari I, Swiatczak B (2022) PROTACs: the future of leukemia therapeutics. Front Cell Dev Biol 10:851087. https://doi.org/10.3389/fcell.2022.851087 citation_journal_title=Exp Biol Med (Maywood); citation_title=Overexpression of HOXA10 promotes the growth and metastasis of nasopharyngeal carcinoma; citation_author=D Gong, H Zhu, L Zeng, R Hu, J Hu, J Ding; citation_volume=246; citation_publication_date=2021; citation_pages=2454-2462; citation_doi=10.1177/15353702211030854; citation_id=CR208 citation_journal_title=Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine; citation_title=FBW7 increases drug sensitivity to cisplatin in human nasopharyngeal carcinoma by downregulating the expression of multidrug resistance-associated protein; citation_author=Y Song, X Zhou, W Bai, X Ma; citation_volume=36; citation_publication_date=2015; citation_pages=4197-4202; citation_doi=10.1007/s13277-015-3056-4; citation_id=CR209 citation_journal_title=Theranostics; citation_title=Polo-Like Kinase 1 phosphorylates and stabilizes KLF4 to promote tumorigenesis in nasopharyngeal carcinoma; citation_author=J Mai, ZY Zhong, GF Guo, XX Chen, YQ Xiang, X Li, HL Zhang, YH Chen, XL Xu, RY Wu; citation_volume=9; citation_publication_date=2019; citation_pages=3541-3554; citation_doi=10.7150/thno.32908; citation_id=CR210 citation_journal_title=Oncol Res; citation_title=Increased expression of Cullin 3 in nasopharyngeal carcinoma and knockdown inhibits proliferation and invasion; citation_author=R Zeng, G Tan, W Li, Y Ma; citation_volume=26; citation_publication_date=2018; citation_pages=111-122; citation_doi=10.3727/096504017x14924753593574; citation_id=CR211 citation_journal_title=Invest New Drugs; citation_title=Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma; citation_author=WL Gluck, MM Gounder, R Frank, F Eskens, JY Blay, PA Cassier, JC Soria, S Chawla, V Weger, AJ Wagner; citation_volume=38; citation_publication_date=2020; citation_pages=831-843; citation_doi=10.1007/s10637-019-00840-1; citation_id=CR212 citation_journal_title=Cancer Sci; citation_title=Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: a phase I study; citation_author=S Takahashi, Y Fujiwara, K Nakano, T Shimizu, J Tomomatsu, T Koyama, M Ogura, M Tachibana, Y Kakurai, T Yamashita; citation_volume=112; citation_publication_date=2021; citation_pages=2361-2370; citation_doi=10.1111/cas.14875; citation_id=CR213